Trial Profile

Anti-oxidant Therapy and Postoperative Cardiac Events (ACE) Trial, Preoperative Intervention in Vascular Surgery

Status: Active, no longer recruiting

Phase of Trial: Phase 0

Latest Information Update: 03 Aug 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ubidecarenone (Primary)
Indications Heart failure; Myocardial infarction
Focus Adverse reactions; Therapeutic Use
Acronyms ACE

Most Recent Events

30 Aug 2021 Planned primary completion date changed from 4 Aug 2021 to 4 Aug 2022.
18 Nov 2019 Results (n=123) presented at the American Heart Association Scientific Sessions 2019
22 May 2019 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com